Pharmaceuticals

Balancing profitability and mission

bexib
By bexib 0 Min Read

In this portion of our video interviews with pharmaceutical executives, Brian Hillberdink, EVP of LEO Pharma and president of LEO Pharma’s U.S. affiliate, talks about how he balances the need for profitability with the mission of providing treatments for rare diseases.

You Might Also Like

Imbruvica Demonstrates Long-Term Effectiveness and Safety in First-Line Treatment of Chronic Lymphocytic Leukemia

Synthetic Lethality: Q&A with Oren Gilad, CEO of Aprea Therapeutics

Pharma Pulse 6/3/24: Impact of serialization technology, strategies to help health plans prepare for risk adjustment, and more

AI Paradigm Shift: How Cutting-Edge Technology Will Accelerate the Future of Medicine

Pharma Pulse 6/10/24: How Serious Are You About Patient-Centricity? Mark Cuban Talks Drug Prices and More

Share This Article
Previous Article Why Did US Quietly Reverse Its Decision to Unilaterally Recognise Venezuela’s Opposition Candidate As President?
Next Article Binance Labs Invests in Solayer for Solana Re-Staking – Investorempires.com
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Pentagon blacklist increases scrutiny of China’s shipbuilding industry
Manufacturing
Government subsidies for organic farming in India: Financial aid for sustainability
Agro Businesses
Chart: US Consumer Digital Habits 2024
Retail & E-commerce
SEG Automotive introduces advanced e-mobility solutions for Indian market
Manufacturing